AU2011310663A1 - Apoptosis imaging agents based on lantibiotic peptides - Google Patents

Apoptosis imaging agents based on lantibiotic peptides Download PDF

Info

Publication number
AU2011310663A1
AU2011310663A1 AU2011310663A AU2011310663A AU2011310663A1 AU 2011310663 A1 AU2011310663 A1 AU 2011310663A1 AU 2011310663 A AU2011310663 A AU 2011310663A AU 2011310663 A AU2011310663 A AU 2011310663A AU 2011310663 A1 AU2011310663 A1 AU 2011310663A1
Authority
AU
Australia
Prior art keywords
chelator
conjugate
imaging agent
imaging
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2011310663A
Other languages
English (en)
Inventor
Bente Elizabeth Arbo
Rajiv Bhalla
Matthias Eberhard Glaser
Duncan Hiscock
Bard Indrevoll
Graeme Walter Mcrobbie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Publication of AU2011310663A1 publication Critical patent/AU2011310663A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2011310663A 2010-09-27 2011-09-27 Apoptosis imaging agents based on lantibiotic peptides Abandoned AU2011310663A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1016206.3 2010-09-27
GBGB1016206.3A GB201016206D0 (en) 2010-09-27 2010-09-27 Apoptosis imaging agents
PCT/EP2011/066789 WO2012041862A1 (en) 2010-09-27 2011-09-27 Apoptosis imaging agents based on lantibiotic peptides

Publications (1)

Publication Number Publication Date
AU2011310663A1 true AU2011310663A1 (en) 2013-03-28

Family

ID=43128013

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011310663A Abandoned AU2011310663A1 (en) 2010-09-27 2011-09-27 Apoptosis imaging agents based on lantibiotic peptides

Country Status (13)

Country Link
US (1) US20130189186A1 (enExample)
EP (1) EP2621545A1 (enExample)
JP (1) JP2013538819A (enExample)
KR (1) KR20130097780A (enExample)
CN (1) CN103118710A (enExample)
AU (1) AU2011310663A1 (enExample)
BR (1) BR112013006536A2 (enExample)
CA (1) CA2810573A1 (enExample)
GB (1) GB201016206D0 (enExample)
MX (1) MX2013003398A (enExample)
RU (1) RU2013113677A (enExample)
SG (1) SG188464A1 (enExample)
WO (1) WO2012041862A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108144073A (zh) * 2017-12-28 2018-06-12 中山大学附属第医院 靶向磷脂酰乙醇胺的放射性标记三聚乙二醇修饰耐久霉素多肽药物
GB201804835D0 (en) * 2018-03-26 2018-05-09 Ge Healthcare As Formulation and method of preparation
EP4057002B1 (en) 2019-11-12 2024-08-07 Ewha University-Industry Collaboration Foundation Cell imaging composition and cellular material imaging method using same
CN113368264B (zh) * 2020-03-09 2022-09-30 南方医科大学南方医院 放射性标记肉桂霉素，其制备方法及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0105224D0 (en) * 2001-03-02 2001-04-18 Nycomed Amersham Plc Improved peptide-chelate conjugates
US7034113B2 (en) * 2002-02-22 2006-04-25 Paradigm Diagnostics, Llc Bacteriocin-metal complexes in the detection of pathogens and other biological analytes
US7879801B2 (en) 2002-07-15 2011-02-01 Board Of Regents, The University Of Texas System Compositions comprising cell-impermeant duramycin derivatives
GB0416062D0 (en) * 2004-07-19 2004-08-18 Amersham Plc Improved N4 chelator conjugates
US20060110323A1 (en) 2004-11-19 2006-05-25 Ming Zhao Method of imaging cell death in vivo
AU2009223677A1 (en) 2008-03-10 2009-09-17 Mcw Research Foundation, Inc. 99mTc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical

Also Published As

Publication number Publication date
SG188464A1 (en) 2013-04-30
US20130189186A1 (en) 2013-07-25
JP2013538819A (ja) 2013-10-17
MX2013003398A (es) 2013-05-30
KR20130097780A (ko) 2013-09-03
BR112013006536A2 (pt) 2016-05-31
EP2621545A1 (en) 2013-08-07
GB201016206D0 (en) 2010-11-10
WO2012041862A1 (en) 2012-04-05
CA2810573A1 (en) 2012-04-05
RU2013113677A (ru) 2014-11-10
CN103118710A (zh) 2013-05-22

Similar Documents

Publication Publication Date Title
CN101454026B (zh) 成像剂
KR100892009B1 (ko) 개질된 킬레이터 콘쥬게이트
IL268974A (en) Marked inhibitors of prostate-specific membrane antigen (psma), their use as imaging agents and as pharmaceuticals for the treatment of prostate cancer
TW200944239A (en) Bombesin analog peptide antagonist conjugates
AU2002317317A1 (en) Improved chelator conjugates
AU2011334966A1 (en) Apoptosis pet imaging agents
EP2680888B1 (en) Technetium labelled peptides
CA2346154A1 (en) Gastrin receptor-avid peptide conjugates
AU2011310663A1 (en) Apoptosis imaging agents based on lantibiotic peptides
US7481993B2 (en) Chelators for radioactively labeled conjugates comprising a stabilizing sidechain
HK1064585B (en) Improved chelator conjugates

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted